BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 17014394)

  • 21. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus.
    Dunn C; Curran MP
    Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insuline glusine (Apidra): a new rapid-acting insulin.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of inhaled insulin.
    Mastrandrea LD; Quattrin T
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1061-75. PubMed ID: 17070613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
    Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
    Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled insulin.
    Arnolds S; Heise T
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):555-71. PubMed ID: 18054735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled human insulin.
    Strack TR
    Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled human insulin.
    Owens DR; Grimley J; Kirkpatrick P
    Nat Rev Drug Discov; 2006 May; 5(5):371-2. PubMed ID: 16802444
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.
    de Galan BE; Simsek S; Tack CJ; Heine RJ
    Neth J Med; 2006 Oct; 64(9):319-25. PubMed ID: 17057268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis.
    Pittas AG; Westcott GP; Balk EM
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes.
    Ellis SL; Gemperline KA; Garg SK
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S48-56. PubMed ID: 17563304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new therapeutic option for diabetes patients].
    Mihălţan F; Ulmeanu R; Râşnoveanu R
    Pneumologia; 2005; 54(4):181-5. PubMed ID: 17069221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhaled insulin: a new route in the optimisation of glucose regulation].
    Luik PT; Veneman TF
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):833-8. PubMed ID: 16676512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
    Kanna B; Abreu-Pacheco H
    Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practice.
    Heine RJ
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S19-23. PubMed ID: 16135135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
    Pfützner A; Forst T
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled insulin: a novel and non-invasive way for insulin administration?
    Quattrin T
    Curr Drug Saf; 2006 May; 1(2):151-8. PubMed ID: 18690926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin glulisine. Aventis Pharma.
    Barlocco D
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1240-4. PubMed ID: 14649217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.